Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112


Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy.

Lai S, Muscaritoli M, Andreozzi P, Sgreccia A, De Leo S, Mazzaferro S, Mitterhofer AP, Pasquali M, Protopapa P, Spagnoli A, Amabile MI, Molfino A.

Nutrition. 2018 Dec 11;62:108-114. doi: 10.1016/j.nut.2018.12.005. [Epub ahead of print]


Nutrition support for treating cancer-associated weight loss: an update.

Molfino A, Amabile MI, Muscaritoli M.

Curr Opin Support Palliat Care. 2018 Dec;12(4):434-438. doi: 10.1097/SPC.0000000000000383.


Peritoneal dialysis in older adults: Evaluation of clinical, nutritional, metabolic outcomes, and quality of life.

Lai S, Amabile MI, Bargagli MB, Musto TG, Martinez A, Testorio M, Mastroluca D, Lai C, Aceto P, Molfino A; Study Group on Geriatric Nephrology of the Italian Society of Nephrology (SIN).

Medicine (Baltimore). 2018 Aug;97(35):e11953. doi: 10.1097/MD.0000000000011953.


Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients.

Gigli S, Amabile MI, David E, De Luca A, Grippo C, Manganaro L, Monti M, Ballesio L.

Acad Radiol. 2018 Aug 23. pii: S1076-6332(18)30328-3. doi: 10.1016/j.acra.2018.06.014. [Epub ahead of print]


PTEN expression and its association with glucose control and calorie supplementation in critically ill patients.

Molfino A, Alessandri F, Mosillo P, Dell'Utri D, Farcomeni A, Amabile MI, Laviano A.

Clin Nutr. 2018 Dec;37(6 Pt A):2186-2190. doi: 10.1016/j.clnu.2017.10.021. Epub 2017 Nov 4.


Magnetic Resonance Imaging after Breast Oncoplastic Surgery: An Update.

Gigli S, Amabile MI, Di Pastena F, Manganaro L, David E, Monti M, DʼOrazi V, Catalano C, Ballesio L.

Breast Care (Basel). 2017 Sep;12(4):260-265. doi: 10.1159/000477896. Epub 2017 Aug 10. Review.


Anti-catabolic neurohormonal blockade to improve skeletal muscle during disease.

Molfino A, Amabile MI, Muscaritoli M.

Expert Opin Biol Ther. 2017 Dec;17(12):1583. doi: 10.1080/14712598.2017.1392029. Epub 2017 Oct 23. No abstract available.


Corrigendum: Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function.

Lai S, Amabile MI, Altieri S, Mastroluca D, Lai C, Aceto P, Crudo M, D'Angelo AR, Muscaritoli M, Molfino A.

Front Nutr. 2017 Oct 4;4:44. doi: 10.3389/fnut.2017.00044. eCollection 2017.


Lipofilling Outcomes Mimicking Breast Cancer Recurrence: Case Report and Update of the Literature.

Gigli S, Amabile MI, DI Pastena F, DE Luca A, Gulia C, Manganaro L, Monti M, Ballesio L.

Anticancer Res. 2017 Oct;37(10):5395-5398. Review.


Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients.

Molfino A, Amabile MI, Mazzucco S, Biolo G, Farcomeni A, Ramaccini C, Antonaroli S, Monti M, Muscaritoli M.

Front Physiol. 2017 Jul 28;8:549. doi: 10.3389/fphys.2017.00549. eCollection 2017.


Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?

Molfino A, Amabile MI, Monti M, Muscaritoli M.

Oxid Med Cell Longev. 2017;2017:5987082. doi: 10.1155/2017/5987082. Epub 2017 Jun 14. Review.


Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function.

Lai S, Amabile MI, Altieri S, Mastroluca D, Lai C, Aceto P, Crudo M, D'Angelo AR, Muscaritoli M, Molfino A.

Front Nutr. 2017 Mar 17;4:4. doi: 10.3389/fnut.2017.00004. eCollection 2017. Erratum in: Front Nutr. 2017 Oct 04;4:44.


The metabolite beta-aminoisobutyric acid and physical inactivity among hemodialysis patients.

Molfino A, Amabile MI, Ammann T, Farcomeni A, Lionetto L, Simmaco M, Lai S, Laviano A, Rossi Fanelli F, Chiappini MG, Muscaritoli M.

Nutrition. 2017 Feb;34:101-107. doi: 10.1016/j.nut.2016.07.012. Epub 2016 Jul 30.


Plasma Cell Mastitis in Men: A Single-center Experience and Review of the Literature.

Palmieri A, D'Orazi V, Martino G, Frusone F, Crocetti D, Amabile MI, Monti M.

In Vivo. 2016 11-12;30(6):727-732. Review.


Oncoplastic central quadrantectomies.

Pasta V, D'Orazi V, Merola R, Frusone F, Amabile MI, De Luca A, Buè R, Monti M.

Gland Surg. 2016 Aug;5(4):422-6. doi: 10.21037/gs.2016.04.01. Review.


Foods and their components promoting gastrointestinal cancer.

Muscaritoli M, Amabile MI, Molfino A.

Curr Opin Clin Nutr Metab Care. 2016 Sep;19(5):377-381. doi: 10.1097/MCO.0000000000000309.


Novel therapeutic options for cachexia and sarcopenia.

Molfino A, Amabile MI, Rossi Fanelli F, Muscaritoli M.

Expert Opin Biol Ther. 2016 Oct;16(10):1239-44. doi: 10.1080/14712598.2016.1208168. Epub 2016 Jul 11. Review.


Wire-guided Localization in Non-palpable Breast Cancer: Results from Monocentric Experience.

Tardioli S, Ballesio L, Gigli S, DI Pastena F, D'Orazi V, Giraldi G, Monti M, Amabile MI, Pasta V.

Anticancer Res. 2016 May;36(5):2423-7.


The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast Cancer.

Molfino A, Amabile MI, Monti M, Arcieri S, Rossi Fanelli F, Muscaritoli M.

Int J Mol Sci. 2016 Apr 5;17(4):505. doi: 10.3390/ijms17040505. Review.


Nipple-sparing Mastectomy in Patients with Preoperative Diagnosis of Non-invasive Breast Carcinoma. A Single-center Experience.

Amabile MI, Monti M, Merola R, Frusone F, D'Orazi V, Pasta V.

Anticancer Res. 2016 Feb;36(2):779-83.


Carnitine for the treatment of cachexia: Lights and shadows.

Molfino A, Amabile MI, Monti M, Rossi Fanelli F, Muscaritoli M.

Int J Cardiol. 2015 Nov 1;198:180-1. doi: 10.1016/j.ijcard.2015.06.156. Epub 2015 Jul 2. No abstract available.


Factors Predictive of Re-excision After Oncoplastic Breast-conserving Surgery.

Amabile MI, Mazouni C, Guimond C, Sarfati B, Leymarie N, Cloutier AS, Bentivegna E, Garbay JR, Kolb F, Rimareix F.

Anticancer Res. 2015 Jul;35(7):4229-34.


Quilting Sutures Reduces Seroma in Mastectomy.

Mazouni C, Mesnard C, Cloutier AS, Amabile MI, Bentivegna E, Garbay JR, Sarfati B, Leymarie N, Kolb F, Rimareix F.

Clin Breast Cancer. 2015 Aug;15(4):289-93. doi: 10.1016/j.clbc.2014.12.014. Epub 2015 Jan 9.


TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Bartucci M, Dattilo R, Moriconi C, Pagliuca A, Mottolese M, Federici G, Benedetto AD, Todaro M, Stassi G, Sperati F, Amabile MI, Pilozzi E, Patrizii M, Biffoni M, Maugeri-Saccà M, Piccolo S, De Maria R.

Oncogene. 2015 Feb 5;34(6):681-90. doi: 10.1038/onc.2014.5. Epub 2014 Feb 17.


Metal-on-metal hip prostheses: correlation between debris in the synovial fluid and levels of cobalt and chromium ions in the bloodstream.

De Pasquale D, Stea S, Squarzoni S, Bordini B, Amabile M, Catalani S, Apostoli P, Toni A.

Int Orthop. 2014 Mar;38(3):469-75.


Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.

Arpinati M, Tolomelli G, Bochicchio MT, Castagnetti F, Amabile M, Bandini G, Bonifazi F, Stanzani M, Rosti G, Martinelli G, Baccarani M.

Biol Blood Marrow Transplant. 2013 May;19(5):735-40. doi: 10.1016/j.bbmt.2013.01.007. Epub 2013 Jan 17.


Breast sarcoma in a pregnant patient A case report.

Pasta V, Amabile MI, Bizzarri M, Monti M.

Ann Ital Chir. 2012 Sep 28;2012. pii: S2239253X12020178.


Personal technique for treatment of perianal fistulas in outpatients.

Pasta V, Redler A, Amabile MI, Merola R, Monti M.

Ann Ital Chir. 2012 May-Jun;83(3):269-72.


Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party.

Gugliotta G, Castagnetti F, Palandri F, Breccia M, Intermesoli T, Capucci A, Martino B, Pregno P, Rupoli S, Ferrero D, Gherlinzoni F, Montefusco E, Bocchia M, Tiribelli M, Pierri I, Grifoni F, Marzocchi G, Amabile M, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M, Rosti G; Gruppo Italiano Malattie Ematologiche dell'Adulto CML Working Party.

Blood. 2011 May 26;117(21):5591-9. doi: 10.1182/blood-2010-12-324228. Epub 2011 Mar 30.


Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.

Marzocchi G, Castagnetti F, Luatti S, Baldazzi C, Stacchini M, Gugliotta G, Amabile M, Specchia G, Sessarego M, Giussani U, Valori L, Discepoli G, Montaldi A, Santoro A, Bonaldi L, Giudici G, Cianciulli AM, Giacobbi F, Palandri F, Pane F, Saglio G, Martinelli G, Baccarani M, Rosti G, Testoni N; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Working Party on Chronic Myeloid Leukemia.

Blood. 2011 Jun 23;117(25):6793-800. doi: 10.1182/blood-2011-01-328294. Epub 2011 Mar 29.


Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis.

Soverini S, Vitale A, Poerio A, Gnani A, Colarossi S, Iacobucci I, Cimino G, Elia L, Lonetti A, Vignetti M, Paolini S, Meloni G, di Maio V, Papayannidis C, Amabile M, Guarini A, Baccarani M, Martinelli G, Foà R.

Haematologica. 2011 Apr;96(4):552-7. doi: 10.3324/haematol.2010.034173. Epub 2010 Dec 29.


[Comparison of plasma matrix metalloproteases 2, 3, 9 in breast carcinomas and fibroadenomas].

Solai F, Nardo T, Patrizi G, Annessi M, Santulli M, Amabile MI, Vasaturo F.

G Chir. 2010 Aug-Sep;31(8-9):365-7. Italian.


Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.

Castagnetti F, Testoni N, Luatti S, Marzocchi G, Mancini M, Kerim S, Giugliano E, Albano F, Cuneo A, Abruzzese E, Martino B, Palandri F, Amabile M, Iacobucci I, Alimena G, Pane F, Martinelli G, Saglio G, Baccarani M, Rosti G.

J Clin Oncol. 2010 Jun 1;28(16):2748-54. doi: 10.1200/JCO.2009.26.7963. Epub 2010 May 3.


The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.

Palandri F, Castagnetti F, Iacobucci I, Martinelli G, Amabile M, Gugliotta G, Poerio A, Testoni N, Breccia M, Bocchia M, Crugnola M, Rege-Cambrin G, Martino B, Pierri I, Radaelli F, Specchia G, Pane F, Saglio G, Rosti G, Baccarani M.

Haematologica. 2010 Aug;95(8):1415-9. doi: 10.3324/haematol.2009.021246. Epub 2010 Mar 19.


Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.

Lemoli RM, Salvestrini V, Bianchi E, Bertolini F, Fogli M, Amabile M, Tafuri A, Salati S, Zini R, Testoni N, Rabascio C, Rossi L, Martin-Padura I, Castagnetti F, Marighetti P, Martinelli G, Baccarani M, Ferrari S, Manfredini R.

Blood. 2009 Dec 10;114(25):5191-200. doi: 10.1182/blood-2008-08-176016.


Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia.

Rosti G, Palandri F, Castagnetti F, Breccia M, Levato L, Gugliotta G, Capucci A, Cedrone M, Fava C, Intermesoli T, Cambrin GR, Stagno F, Tiribelli M, Amabile M, Luatti S, Poerio A, Soverini S, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M; GIMEMA CML Working Party.

Blood. 2009 Dec 3;114(24):4933-8. doi: 10.1182/blood-2009-07-232595. Epub 2009 Oct 12.


Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.

Testoni N, Marzocchi G, Luatti S, Amabile M, Baldazzi C, Stacchini M, Nanni M, Rege-Cambrin G, Giugliano E, Giussani U, Abruzzese E, Kerim S, Grimoldi MG, Gozzetti A, Crescenzi B, Carcassi C, Bernasconi P, Cuneo A, Albano F, Fugazza G, Zaccaria A, Martinelli G, Pane F, Rosti G, Baccarani M.

Blood. 2009 Dec 3;114(24):4939-43. doi: 10.1182/blood-2009-07-229864. Epub 2009 Oct 1.


Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.

Palandri F, Castagnetti F, Soverini S, Poerio A, Gugliotta G, Luatti S, Amabile M, Martinelli G, Rosti G, Baccarani M.

Haematologica. 2009 Dec;94(12):1758-61. doi: 10.3324/haematol.2009.010496. Epub 2009 Jul 16.


Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.

Soverini S, Gnani A, Colarossi S, Castagnetti F, Abruzzese E, Paolini S, Merante S, Orlandi E, de Matteis S, Gozzini A, Iacobucci I, Palandri F, Gugliotta G, Papayannidis C, Poerio A, Amabile M, Cilloni D, Rosti G, Baccarani M, Martinelli G.

Blood. 2009 Sep 3;114(10):2168-71. doi: 10.1182/blood-2009-01-197186. Epub 2009 Jul 9.


[Pilonidal sinus. Outpatient treatment with local anesthesia].

Biffoni M, Scipioni P, Macrina N, Amabile MI, Garritano S, Maturo A, Monti M.

G Chir. 2009 Apr;30(4):173-6. Italian.


[Advantages and limits of tumescent anesthesia in outpatient surgery].

Pasta V, Urciuoli P, Macrina N, Amabile MI, Chiarini S, Maturo A, Vergine M, Santucci E, Biffoni M, Scipioni P, Monti M.

G Chir. 2009 Mar;30(3):112-6. Italian.


[Diagnostic and surgical problems of ectopic breast cancer].

Pasta V, Martino G, Vergine M, Scipioni P, Amabile MI, Cardarelli A, Palmieri A, Santucci E, Chiarini S, Monti M.

G Chir. 2009 Jan-Feb;30(1-2):36-40. Italian.


Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party.

Castagnetti F, Palandri F, Amabile M, Testoni N, Luatti S, Soverini S, Iacobucci I, Breccia M, Rege Cambrin G, Stagno F, Specchia G, Galieni P, Iuliano F, Pane F, Saglio G, Alimena G, Martinelli G, Baccarani M, Rosti G; GIMEMA CML Working Party.

Blood. 2009 Apr 9;113(15):3428-34. doi: 10.1182/blood-2007-08-103499. Epub 2009 Feb 11.


[Mucinous gastric adenocarcinoma and duodenal somato-statinoma. Case report].

Biffoni M, Macrina N, Napoli A, Amabile MI, Cavallo Marincola B, Anzidei M, Catalano C, Maturo A, Pasta V.

G Chir. 2008 Aug-Sep;29(8-9):339-42. Italian.


Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.

Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani E, Paolini S, Papayannidis C, Piccaluga PP, Giannoulia P, Soverini S, Amabile M, Poerio A, Saglio G, Pane F, Berton G, Baruzzi A, Vitale A, Chiaretti S, Perini G, Foà R, Baccarani M, Martinelli G.

Blood. 2008 Nov 1;112(9):3847-55. doi: 10.1182/blood-2007-09-112631. Epub 2008 Jul 23. Erratum in: Blood. 2010 Sep 23;116(12):2196.


Outpatient experimental treatment for uncomplicated perianal fistulas.

Pasta V, D'Andrea V, Amabile MI, Vergine M, Macrina N, Biffoni M, Monti M.

Int Surg. 2008 Jul-Aug;93(4):202-5.


[Diagnostic value of out-patient lymph node biopsy].

Biffoni M, Macrina N, Amabile MI, Scipioni P, Palmieri A, Maturo A, La Gumina G, Petullà M, Monti M.

G Chir. 2008 Apr;29(4):182-5. Italian.


[Seroma in residual fibrous capsule after breast implant explantation: a case report].

Vergine M, Ballesio L, Amabile MI, Macrina N, Palmieri A, Martino G, Pasta V.

G Chir. 2008 Apr;29(4):169-71. Italian.


Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome.

Palandri F, Iacobucci I, Castagnetti F, Testoni N, Poerio A, Amabile M, Breccia M, Intermesoli T, Iuliano F, Rege-Cambrin G, Tiribelli M, Miglino M, Pane F, Saglio G, Martinelli G, Rosti G, Baccarani M; GIMEMA Working Party on CML.

Haematologica. 2008 May;93(5):770-4. doi: 10.3324/haematol.12265. Epub 2008 Mar 26.


A case of coexistence between JAK2V617F and BCR /ABL.

Pardini S, Fozza C, Contini S, Rimini E, Ottaviani E, Amabile M, Rosti G, Longinotti M.

Eur J Haematol. 2008 Jul;81(1):75-6. doi: 10.1111/j.1600-0609.2008.01063.x. Epub 2008 Mar 10. No abstract available.


Supplemental Content

Loading ...
Support Center